SELLAS Life Sciences Group's total assets for Q4 2025 were $78.34M, an increase of 51.96% from the previous quarter. SLS total liabilities were $7.47M for the fiscal quarter, a 26.14% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.